Erdoğan, B. R. Et Al. 2019. Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in HFD + low dose STZ diabetes model?. Pharmacology 2019 , (Edinburgh, England), 2604-2605.

Erdoğan, B. R., Yeşilyurt, Z. E., Karaömerlioğlu, İ., Müderrisoğlu, A. E., Sevim, K., & İnan, E. A., (2019). Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in HFD + low dose STZ diabetes model? . Pharmacology 2019 (pp.2604-2605). Edinburgh, England

Erdoğan, Betül Et Al. "Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in HFD + low dose STZ diabetes model?," Pharmacology 2019, Edinburgh, England, 2019

Erdoğan, Betül R. Et Al. "Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in HFD + low dose STZ diabetes model?." Pharmacology 2019 , Edinburgh, England, pp.2604-2605, 2019

Erdoğan, B. R. Et Al. (2019) . "Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in HFD + low dose STZ diabetes model?." Pharmacology 2019 , Edinburgh, England, pp.2604-2605.

@conferencepaper{conferencepaper, author={Betül Rabia Erdoğan Et Al. }, title={Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in HFD + low dose STZ diabetes model?}, congress name={Pharmacology 2019}, city={Edinburgh}, country={England}, year={2019}, pages={2604-2605} }